ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,244Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 1844

$936K Total Retail Price of All Prescriptions

Rank: 62 out of 1844

551 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 551 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,914 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 618 495 1 4
FUROSEMIDE 554 455 2 7
HYDROCODONE-ACETAMINOPHEN 524 271 S3 3 2
LEVOTHYROXINE SODIUM 492 374 4 1
OMEPRAZOLE 482 391 5 5
AMLODIPINE BESYLATE 421 353 6 6
PRAVASTATIN SODIUM 363 234 7 10
WARFARIN SODIUM 310 296 8 13
SIMVASTATIN 310 238 8 3
METFORMIN HCL 224 145 10 8
METOPROLOL TARTRATE 220 155 11 11
RANITIDINE HCL 217 144 12 38
ZOLPIDEM TARTRATE 190 132 13 23
DONEPEZIL HCL 182 182 14 26
METOPROLOL SUCCINATE 169 159 15 14
POTASSIUM CHLORIDE 168 153 16 16
SERTRALINE HCL 159 105 17 21
MIRTAZAPINE 155 121 18 49
ALENDRONATE SODIUM 148 131 19 25
HYDROCHLOROTHIAZIDE 143 109 20 9
GABAPENTIN 140 69 21 15
ATORVASTATIN CALCIUM 136 93 22 12
NAMENDA 131 128 23 33
ADVAIR DISKUS 130 107 24 51
CARVEDILOL 124 89 25 22
PROAIR HFA 124 42 25 45
TRAZODONE HCL 120 69 27 43
SPIRIVA 114 75 28 57
TRAMADOL HCL 112 53 29 18
CITALOPRAM HBR 112 70 29 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 67 31 73
GLIMEPIRIDE 99 56 32 35
ATENOLOL 97 73 33 17
BISOPROLOL-HYDROCHLOROTHIAZIDE 95 72 34 99
CYMBALTA 93 66 35 36
ROPINIROLE HCL 92 50 36 76
PREDNISONE 89 69 37 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 58 37 20
LANTUS 88 73 39 42
PANTOPRAZOLE SODIUM 88 65 39 32
FENOFIBRATE 87 51 41 71
FLUOXETINE HCL 85 54 42 41
CRESTOR 82 38 43 30
AZITHROMYCIN 80 65 44 37
NOVOLOG 79 76 45 84
CIPROFLOXACIN HCL 79 69 45 62
NEXIUM 79 62 45 31
CLOPIDOGREL 79 55 45 34
FENTANYL 77 53 S2 49 66
LOSARTAN POTASSIUM 77 76 49 24
LYRICA 75 44 51 92
KLOR-CON M20 75 44 51 54
TIZANIDINE HCL 74 38 53 141
MELOXICAM 73 47 54 28
TERAZOSIN HCL 73 73 54 136
AMOXICILLIN 71 49 56 101
POLYETHYLENE GLYCOL 3350 71 57 56 39
FAMOTIDINE 69 39 58 63
ALLOPURINOL 69 57 58 29
GLYBURIDE-METFORMIN HCL 64 52 R 60 140
ESCITALOPRAM OXALATE 64 33 60 52
PAROXETINE HCL 63 50 62 68
GLIPIZIDE ER 63 48 62 79
TRIAMTERENE-HCTZ 63 54 62 48
INSULIN SYRINGE 61 47 65 111
BUSPIRONE HCL 60 30 66 127
PEN NEEDLE 60 25 66 135
DIGOXIN 60 56 66 67
COMBIVENT 59 26 69 131
GLIPIZIDE 59 35 69 70
METFORMIN HCL ER 59 45 69 46
LANSOPRAZOLE 55 35 72 194
OLANZAPINE 54 51 73 117
QUETIAPINE FUMARATE 54 30 73 82
FLUTICASONE PROPIONATE 54 39 73 50
JANUVIA 53 26 76 77
CYCLOBENZAPRINE HCL 53 14 R 76 53
TAMSULOSIN HCL 51 38 78 27
DOXAZOSIN MESYLATE 50 47 79 110
DIVALPROEX SODIUM 50 42 79 74
VENTOLIN HFA 50 39 79 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.